SMTL ID : 1pme.1

STRUCTURE OF PENTA MUTANT HUMAN ERK2 MAP KINASE COMPLEXED WITH A SPECIFIC INHIBITOR OF HUMAN P38 MAP KINASE

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 3 residues within 4Å: Chain A: R.211, R.214, Y.253 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:Y.253 Water bridges: A:R.214 Salt bridges: A:R.211, A:R.214

1 x SB2: 4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE(Non-covalent)

SB2.2: 15 residues within 4Å: Chain A: V.59, A.72, K.74, L.123, V.124, T.125, H.126, L.127, M.128, K.171, S.173, N.174, L.176, C.186, D.187 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:A.72, A:K.74, A:T.125, A:L.176 Hydrogen bonds: A:M.128 Water bridges: A:K.74 Salt bridges: A:D.187

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Fox, T. et al., A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase. Protein Sci. (1998)

Release Date

1999-06-08

Peptides

ERK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

ERK2